Byrna (BYRN) 10-K/A 20 Oct 15 2014 FY Annual report (amended) Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Nov. 30, 2014	Feb. 18, 2015	May. 31, 2014
Document Type	10-K
Amendment Flag	false
Document Period End Date	Nov. 30, 2014
Trading Symbol	sdev
Entity Registrant Name	Security Devices International Inc.
Entity Central Index Key	1,354,866
Current Fiscal Year End Date	--11-30
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		46,899,285
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well Known Seasoned Issuer	No
Entity Public Float			$ 9,336,000
Document Fiscal Year Focus	2,014
Document Fiscal Period Focus	FY

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Nov. 30, 2014	Nov. 30, 2013
CURRENT
Cash and cash equivalents	$ 1,085,006	$ 1,842,149
Accounts Receivable	7,393	20,351
Inventory	120,246	0
Deferred financing costs	170,674	0
Prepaid expenses and other receivables	29,557	45,372
Total Current Assets	1,412,876	1,907,872
Plant and Equipment	144,176	152,137
TOTAL ASSETS	1,557,052	2,060,009
CURRENT LIABILITIES
Accounts payable and accrued liabilities	161,405	106,529
Total Current Liabilities	161,405	106,529
Convertible Debentures	1,398,592	0
Total Liabilities	1,559,997	106,529
Capital Stock
Preferred stock, $0.001 par value, 5,000,000 shares authorized, Nil issued and outstanding (2013 - nil). The provisions in the Articles of Incorporation allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of Company's common stock.	0	0
Common stock, $0.001 par value 100,000,000 shares authorized, 46,899,285 issued and outstanding (2013: 46,849,285)	46,899	46,849
Additional Paid-In Capital	24,024,631	23,226,988
Deficiency	(24,042,769)	(21,320,357)
Accumulated other comprehensive loss	(31,706)	0
Total Stockholders' Equity (Deficiency)	(2,945)	1,953,480
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIENCY)	$ 1,557,052	$ 2,060,009

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Nov. 30, 2014	Nov. 30, 2013
Preferred Stock, Par Value Per Share	$ 0.001	$ 0.001
Preferred Stock, Shares Authorized	5,000,000	5,000,000
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Par Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	100,000,000	100,000,000
Common Stock, Shares, Issued	46,899,285	46,849,285
Common Stock, Shares, Outstanding	46,899,285	46,849,285

Consolidated Statements of Oper

Consolidated Statements of Operations and Comprehensive loss - USD ($)	12 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
SALES	$ 42,480	$ 30,096
COST OF SALES	(27,323)	(17,379)
GROSS PROFIT	15,157	12,717
EXPENSES:
Depreciation	45,586	38,130
General and administration	2,624,488	1,698,523
TOTAL OPERATING EXPENSES	2,670,074	1,736,653
LOSS FROM OPERATIONS	(2,654,917)	(1,723,936)
Other expense-Interest	(73,540)	(651,502)
Other Income-Derivative financial instrument	0	349,532
Other Income-Interest	6,045	1,695
LOSS BEFORE INCOME TAXES	(2,722,412)	(2,024,211)
Income taxes	0	0
NET LOSS	(2,722,412)	(2,024,211)
Foreign exchange translation adjustment for the year	(31,706)	0
COMPREHENSIVE LOSS	$ (2,754,118)	$ (2,024,211)
Loss per share - basic and diluted	$ (0.06)	$ (0.06)
Weighted average number of common shares outstanding during the year	46,868,052	36,565,840

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss for the year	$ (2,722,412)	$ (2,024,211)
Items not requiring an outlay of cash:
Fair value of options and warrants (included in general and administration expenses)	751,610	0
Amortization of deferred financing costs	20,202	0
Depreciation	45,586	38,130
Interest on convertible debt converted to stock	0	79,752
Amortization of debt discount	0	537,488
Gain on extinguishment of debt included in general and administration expenses	0	(33,501)
Derivative financial instrument	0	(349,532)
Changes in non-cash working capital:
Accounts receivable	12,816	(20,351)
Inventory	(120,246)	0
Prepaid expenses and other receivables	14,635	(38,172)
Deferred costs	0	32,500
Accounts payable and accrued liabilities*	57,759	45,940
NET CASH USED IN OPERATING ACTIVITIES	(1,940,050)	(1,731,957)
CASH FLOWS FROM INVESTING ACTIVITIES
Acquisition of Plant and Equipment	(37,625)	(45,219)
NET CASH USED IN INVESTING ACTIVITIES	(37,625)	(45,219)
CASH FLOWS FROM FINANCING ACTIVITIES
Net Proceeds from issuance of common stock	0	3,069,700
Net proceeds from convertible debentures	1,241,299	0
Repayment of convertible debentures	0	(30,000)
Exercise of stock options	12,500	0
Proceeds from bridge loans	0	641,965
Repayment of bridge loans	0	(294,811)
NET CASH PROVIDED BY FINANCING ACTIVITIES	1,253,799	3,386,854
Effects of foreign currency exchange rate changes	(33,267)	0
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS FOR THE YEAR	(757,143)	1,609,678
Cash and cash equivalents , beginning of Year	1,842,149	232,471
CASH AND CASH EQUIVALENTS END OF YEAR	1,085,006	1,842,149
SUPPLEMENTAL INFORMATION:
INCOME TAXES PAID	0	0
INTEREST PAID	$ 0	$ 39,545

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders Equity - USD ($)	Common Shares [Member]	Additional Paid-In Capital [Member]	Deficiency [Member]	Accumulated Other Comprehensive loss [Member]	Total
Beginning Balance at Nov. 30, 2012	$ 31,472	$ 18,338,886	$ (19,296,146)	$ 0	$ (925,788)
Beginning Balance (Shares) at Nov. 30, 2012	31,472,433
Conversion of convertible debt to common shares	$ 1,802	538,642			540,444
Conversion of convertible debt to common shares (Shares)	1,801,480
Conversion of convertible debt to common shares2	$ 2,297	795,419			797,716
Conversion of convertible debt to common shares2 (Shares)	2,297,044
Issuance of common shares for cash	$ 9,985	3,059,715			3,069,700
Issuance of common shares for cash (Shares)	9,984,950
Common share reconciliation difference with transfer agent	$ 20	(20)
Common share reconciliation difference with transfer agent (Shares)	20,000
Relative fair value of detachable 325,000 warrants component of bridge loans financing		77,537			77,537
Conversion of bridge loans with accrued interest to common shares	$ 1,273	416,809			418,082
Conversion of bridge loans with accrued interest to common shares (Shares)	1,273,378
Net loss for the period			(2,024,211)		(2,024,211)
Ending Balance at Nov. 30, 2013	$ 46,849	23,226,988	(21,320,357)	0	1,953,480
Ending Balance (Shares) at Nov. 30, 2013	46,849,285
Stock based compensation for issue of options		751,610			751,610
Exercise of options	$ 50	12,450			12,500
Exercise of options (Shares)	50,000
Relative fair value of placement agent warrants		33,583			33,583
Net loss for the period			(2,722,412)		(2,722,412)
Foreign currency translation				(31,706)	(31,706)
Ending Balance at Nov. 30, 2014	$ 46,899	$ 24,024,631	$ (24,042,769)	$ (31,706)	$ (2,945)
Ending Balance (Shares) at Nov. 30, 2014	46,899,285

BASIS OF PRESENTATION

BASIS OF PRESENTATION	12 Months Ended
	Nov. 30, 2014
BASIS OF PRESENTATION [Text Block]	1. BASIS OF PRESENTATION The Company was incorporated under the laws of the state of Delaware on March 1, 2005. On February 3, 2014 the Company incorporated a wholly owned subsidiary in Canada “Security Devices International Canada Corp”. The consolidated financial statements include the accounts of Security Devices International, Inc. (the “Company” or “SDI”), and its subsidiary Security Devices International Canada Corp. All material inter- company accounts and transactions have been eliminated.

NATURE OF OPERATIONS AND GOING

NATURE OF OPERATIONS AND GOING CONCERN	12 Months Ended
	Nov. 30, 2014
NATURE OF OPERATIONS AND GOING CONCERN [Text Block]	2. NATURE OF OPERATIONS AND GOING CONCERN The Company is a less-lethal defense technology company, specializing in the innovative next generation solutions for security situations that do not require the use of lethal force. SDI has implemented manufacturing partnerships to assist in the deployment of their patented and patent pending family of products. These products consist of the Blunt Impact Projectile 40mm (BIP) line of products, and the Wireless Electric Projectile 40mm (WEP). These financial statements have been prepared in accordance with generally accepted accounting principles applicable to a going concern, which assumes that the Company will be able to meet its obligations and continue its operations for its next fiscal year. The Company’s activities are subject to risk and uncertainties including- The Company does not have adequate revenue to fund all of its operational needs and may require additional financing to continue its operations if it is unable to generate substantial revenue growth. There can be no assurance that such financing will be available at all or on favorable terms. The Company has incurred a cumulative loss of $24,042,769 from inception to November 30, 2014 which includes a non-cash stock based compensation expense of $7,237,381 for issue of options and warrants. The Company has funded operations through the issuance of capital stock and convertible debentures. The company has started to generate revenue from operations. However, it still expects to incur significant expenses before becoming profitable. The Company’s future success is dependent upon its ability to raise sufficient capital or generate adequate revenue, to cover its ongoing operating expenses, and also to continue to develop and be able to profitably market its products. These factors raise substantial doubt about its ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. In addition to raising funds in the prior years, the Company raised $160,000 through the issuance of 800,000 common shares during the year ended November 30, 2011. The Company further raised an additional $878,328 by issue of Convertible Debentures during the year ended November 30, 2011 and $910,000 during the year ended November 30, 2012. In addition, the Company raised $649,750 by issuance of 2,165,834 common shares during the year ended November 30, 2012. On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario for listing its shares in these provinces in Canada. On August 27, 2013 the Company completed an initial public offering to raise gross proceeds of CAD $3,993,980 (US $3,794,280) through the issuance of 9,984,950 Common Shares at a price of CAD $0.40 (US $0.38) per Common Share (the “Issue Price”). During the year ended November 30, 2014, the Company issued $1,398,592 (CAD $1,549,000) face value 12% convertible debentures with a term to August 6, 2017 (the “Maturity Date”) and raised net $1,241,299. The Company’s common shares commenced trading on the TSX Venture Exchange (“TSX”) under the symbol “SDZ”.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Nov. 30, 2014
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Text Block]	3. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES a) Use of Estimates These financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America. As the precise determination of assets and liabilities, and revenues and expenses, depends on future events, the preparation of financial statements for any period necessarily involves the use of estimates. Actual amounts may differ from these estimates. Significant estimates include accruals, valuation allowance for deferred tax assets, estimates for calculation of stock based compensation, estimating the useful life of its plant and equipment and accounting for conversion features on convertible debt transactions. b) Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10- 25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740- 10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets likely. The Company did not incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company is subject to U.S federal jurisdiction income tax examinations for the tax years 2008 through 2013. In addition, the Company is subject to state and local income tax examinations for the tax years 2008 through 2013. c) Revenue Recognition The Company’s revenue recognition policies follow common practice in the manufacturing industry. The Company records revenue when it is realized, or realizable and earned. The Company considers revenue to be realized, or realizable and earned, when the following revenue recognition requirements are met: persuasive evidence of an arrangement exists; the products or services have been accepted by the customer via delivery or installation acceptance; the sales price is fixed or determinable; and collectability is probable. For product sales, the Company determines that the earnings process is complete when title, risk of loss and the right to use product has transferred to the customer. d) Loss Per Share Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. There were no common equivalent shares outstanding at November 30, 2014 and 2013 that have been included in dilutive loss per share calculation as the effects would have been anti-dilutive. At November 30, 2014, there were 3,360,000 options and 4,794,545 warrants outstanding, which were convertible into equal number of common shares of the Company. At November 30, 2013, there were 1,510,000 options and 5,542,645 warrants outstanding, which were convertible into equal number of common shares of the Company. e) Cash and cash equivalents Cash and cash equivalents include cash on hand, amounts due from banks, and any other highly liquid investments with a maturity of three months or less. The carrying amounts approximate fair values because of the short maturity of those instruments. f) Research and Product Development Research and Product Development costs, other than capital expenditures but including acquired research and product development costs, are charged against income in the period incurred. g) Stock-Based Compensation All awards granted to employees and non-employees after November 30, 2005 are valued at fair value by using the Black-Scholes option pricing model and recognized on a straight line basis over the service periods of each award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees using the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services. As of November 30, 2014 there was $nil of unrecognized expense related to non-vested stock-based compensation arrangements granted. The total stock-based compensation expense relating to all employees and non employees for the years ended November 30, 2014 and 2013 was $751,610 and $Nil respectively. h) Foreign Currency The parent Company maintains its books and records in U.S. dollars which is its functional and reporting currency.The Company’s operating subsidiary is a foreign private company and maintains its books and records in Canadian dollars (the functional currency). The subsidiary’s financial statements are converted to US dollars for consolidation purposes. The translation method used is the current rate method, where the functional currency is the foreign currency. Under the current rate method all assets and liabilities are translated at the current rate, stockholders’ equity accounts are translated at historical rates and revenues and expenses are translated at average rates for the year. Due to the fact that items in the financial statements are being translated at different rates according to their nature, a translation adjustment is created. This translation adjustment has been included in Accumulated Other Comprehensive Income (Loss). i) Comprehensive loss Comprehensive loss includes all changes in equity (net assets) during a period from non- owner sources. Examples of items to be included in comprehensive loss, which are excluded from net loss, include foreign currency translation adjustments and unrealized gains and losses on available-for-sale securities. j) Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable and accounts payable and accrued liabilities. The Company follows ASC 820-10, “Fair Value Measurements and Disclosures” (ASC 820-10), which among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, a three-tier fair value hierarchy has been established, which prioritizes the inputs used in measuring fair value as follows: • Assets that are generally included in this category are cash and cash equivalents comprised of money market funds, restricted cash and short-term investments. • • Assets and liabilities measured at fair value as of November 30, 2014 and 2013 are classified below based on the three fair value hierarchy tiers described above: Carrying Fair Value Value November 30, 2014: Cash and cash equivalents $ 1,085,006 $ 1,085,006 Accounts receivable $ 7,393 $ 7,393 Accounts payable and accrued liabilities $ 161,405 $ 161,405 Convertible debentures $ 1,398,592 $ 1,398,592 Carrying Fair Value Value November 30, 2013: Cash and cash equivalents $ 1,842,149 $ 1,842,149 Accounts receivable $ 20,351 $ 20,351 Accounts payable and accrued liabilities $ 106,529 $ 106,529 Cash and cash equivalents have been measured using Level 1 of the Fair Value Hierarchy. Foreign exchange risk: The Company’s subsidiary conducts its operating activities in Canadian dollars. The Company is therefore subject to gains or losses due to fluctuations in Canadian currency relative to the US dollar. Liquidity risk The Company’s exposure to liquidity risk is dependent on the ability to raise funds to meet commitments and to sustain operations. The company controls its liquidity risk by managing working capital and cash flows. k) Impairment of Long-lived Assets Long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment. If there are indications of impairment, the Company uses future undiscounted cash flows of the related asset or asset group over the remaining life in measuring whether the assets are recoverable. In the event such cash flows are not expected to be sufficient to recover the recorded asset values, the assets are written down to their estimated fair value. l) Concentration of Credit Risk The Company does not have significant off-balance sheet risk or credit concentration. m) Convertible debt instruments The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 Debt with Conversion and Other Options n) Intellectual Property Four patent applications, one for the electrical mechanism and the other three for the mechanical mechanism of the WEP40, have been filed by the Company with the U.S. Patent Office. The Company has been issued four patents. (a) Less-lethal Projectile: This issued patent relates to the Company’s distinctive collapsible ammunition head technology that absorbs kinetic energy of the projectile upon impact. The Corporation’s collapsible head is used in both the BIP and the WEP. (b) Electronic Circuitry for Incapacitating a Living Target: This issued patent relates to the electronic circuitry incapacitation system which forms part of the WEP. The patent describes an electronic circuit which provides an electrical incapacitation current to a living target. (c) Less-lethal Wireless Stun Projectile System for Immobilizing a Target by Neuro-Muscular Disruption: This issued patent describes the process by which the WEP operates with its attachment system to halt a target through a neuro-muscular-disruption system. (d) Autonomous Operation of a Less-lethal Projectile: This pending patent describes a motion sensing system within the WEP. The sensor will monitor movement of the target and enable the electrical output until the target is subdued. The electrical pulse is programmed for an exact time-frame to specifications of the user. The Company’s policy is to write off patent costs as they are incurred. o) Plant and Equipment Plant and equipment are recorded at cost less accumulated depreciation. Depreciation is provided commencing in the month following acquisition using the following annual rate and method: Computer equipment 30% declining balance method Furniture and fixtures 30% declining balance method Leasehold Improvements Moulds straight line over period of lease 20% Straight line over 5 years p) Inventories Inventories are valued at the lower of cost and net realizable value with cost being determined on the first-in, first-out basis for Blunt Impact Projectiles. q) Recent Accounting Pronouncements In June 2014, the FASB issued ASU 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements” In August 2012, the FASB issued ASU 2012-03, Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update) In April 2014, the FASB issued ASU 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity , In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern On January 9, 2015, FASB issued ASU 2015-01, Income Statement- Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items. The ASU eliminates the concept of extraordinary items and the uncertainty in determining when an item is both unusual in nature and infrequent in occurrence This ASU is effective for years beginning after December 15, 2015, with early adoption permitted. The Company is currently assessing the impact of this guidance. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.

ACCOUNTS PAYABLE AND ACCRUED LI

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	12 Months Ended
	Nov. 30, 2014
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES [Text Block]	4. ACCOUNTS PAYABLE AND ACCRUED LIABILITIES 2014 2013 Accounts payable and accrued liabilities are comprised of the following: Trade payables $ 35,885 $ 48,494 Accrued liabilities-accrued interest $ 53,338 $ Accrued liabilities-other liabilities $ 72,182 $ 58,035 $ 161,405 $ 106,529 Accrued liabilities-other liabilities relate primarily to professional fees.

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Nov. 30, 2014
CAPITAL STOCK [Text Block]	5. CAPITAL STOCK a) Authorized 100,000,000 * Common shares, $0.001 par value And 5,000,000 Preferred shares, $0.001 par value *On March 20, 2013 the Company filed with the Secretary of the State of Delaware a certificate of amendment (the “Amendment”) to the Company’s certificate of incorporation. The Amendment increased the number of authorized shares of the Company’s common stock, par value $0.001, from 50,000,000 to 100,000,000 common shares. The Company’s Articles of Incorporation authorize its Board of Directors to issue up to 5,000,000 shares of preferred stock having par value of $0.001. The provisions in the Articles of Incorporation relating to the preferred stock allow the directors to issue preferred stock with multiple votes per share and dividend rights, which would have priority over any dividends paid with respect to the holders of SDI’s common stock. b) Issued 46,899,285 Common shares (2013: 46,849,285 Common shares) c) Changes to Issued Share Capital Year ended November 30, 2014 On July 17, 2014, the Company issued 50,000 shares on exercise of options at $0.25 per share. Year ended November 30, 2013 During the six month period ended May 31, 2013 the Company issued 1,801,480 common shares for conversion of convertible debentures having face value of $500,000 and accrued interest of $40,444. On August 15, 2013, the Company filed an amended and restated final prospectus (the “Prospectus”) in Canada, in the provinces of Alberta, British Columbia and Ontario to list its common shares (“Common Shares”) on the TSXV. On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CAD$0.40) per Common Share (the “Issue Price”). The Company incurred expenses of $724,580 (CAD $734,565) to raise the capital which included a fee of CAD $80,000 paid to a former director and CEO in accordance with the terms of an agreement regarding escrow of shares and a cash commission of CAD$359,458 paid to the Agent. In addition the Company granted warrants to purchase up to 898,645 Common Shares to the Agent and members of its selling group. The warrants entitle the Agent and members of its selling group to purchase Common Shares at a price of CAD$0.40 (US $0.38) per Common Share until August 27, 2015. Upon completion of the Offering, $700,000 face value of convertible debentures along with $97,716 of interest was converted to 2,297,044 Common Shares, resulting in the discharge of those debentures (see note 14). On January 30, 2013, the Company issued a $199,342 (CAD $200,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 100,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $24,246 (see note 15) On March 14, 2013, the Company issued a $97,456 (CAD $100,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 50,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $11,269 On April 12, 2013, the Company issued a $197,355 (CAD $200,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 100,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $20,502. On May 14, 2013, the Company issued a $147,812 (CAD $150,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 75,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $21,520. During the quarter ended November 30, 2013, the holder of bridge loans converted the principal and interest totaling $378,525 into common shares at CAD$0.30 per share, resulting in gain on extinguishment of debt for $33,501.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION	12 Months Ended
	Nov. 30, 2014
STOCK BASED COMPENSATION [Text Block]	6. STOCK BASED COMPENSATION Effective October 30, 2006 the Company adopted the following stock option and stock bonus plans which were replaced by the Incentive Stock Option Plan (the “2013 Plan”) that was issued in May, 2013. Incentive Stock Option Plan Non-Qualified Stock Option Plan Stock Bonus Plan Effective May 31, 2013, the Company adopted an incentive stock option plan (the “2013 Plan”), which replaces the stock option and stock bonus plans that were in place prior to adoption of the 2013 Plan. All outstanding options to purchase Common Shares granted by the Company under the prior plans are now governed by the 2013 Plan and the prior plans (an Incentive Stock Option Plan, a Non-Qualified Stock Option Plan, and a Stock Bonus Plan) have been terminated. Year ended November 30, 2014 On March 19, 2014, the board of directors granted options to five consultants to acquire a total of 400,000 common shares. The 400,000 options were issued at an exercise price of $0.31 (CAD$0.35) per share and vest immediately with an expiry term of three years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 151.63% Market price of Company’s common stock on date of grant of options $ 0.16 Stock-based compensation cost $ 47,897 On May 9, 2014, the board of directors granted options to one director to acquire a total of 600,000 common shares. These options were issued at an exercise price of $0.32 (CAD $0.35) per share and vest immediately with an expiry term of five years. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 205.42% Market price of Company’s common stock on date of grant of options $ 0.24 Stock-based compensation cost $ 140,573 On July 25, 2014, the board of directors granted options to two consultants to acquire a total of 150,000 common shares. These options were issued at an exercise price of $0.32 (CAD $0.35) per share and vest immediately with an expiry date of August 5, 2017. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 152.35% Market price of Company’s common stock on date of grant of options $ 0.28 Stock-based compensation cost $ 33,952 On September 11, 2014, the board of directors granted options to directors and consultants to acquire a total of 1,875,000 common shares. These options were issued at an exercise price of $0.36 (CAD $0.40) per share and vest immediately with an expiry date of September 10, 2019. The fair value of each option used for the purpose of estimating the stock compensation is calculated using the Black-Scholes option pricing model with the following weighted average assumptions: Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 170.42% Market price of Company’s common stock on date of grant of options $ 0.30 Stock-based compensation cost $ 529,188 As of November 30, 2014 there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted. Year ended November 30, 2013 The Company did not issue any options during the year ended November 30, 2013. As of November 30, 2013 there was $Nil of unrecognized expense related to non-vested stock-based compensation arrangements granted. The following table summarizes the options outstanding under the Stock Option Plan: Number of options 2014 2013 Outstanding, beginning of year 1,510,000 1,660,000 Granted 3,025,000 - Expired (125,000 ) (150,000 ) Exercised (50,000 ) - Forfeited (1,000,000 ) - Cancelled - - Outstanding, end of year 3,360,000 1,510,000 Exercisable, end of year 3,360,000 1,510,000 Option price Number of options Expiry date per share 2014 June 15, 2015 $ 0.20 35,000 October 2, 2015 $ 0.42 200,000 October 25, 2016 $ 0.45 100,000 March 18, 2017 $ 0.31 400,000 August 5, 2017 $ 0.32 150,000 May 18, 2019 $ 0.32 600,000 September 10, 2019 $ 0.36 1,875,000 TOTAL 3,360,000 Weighted average exercise price: Options outstanding at end of year $ 0.35 Options granted during the year 0.34 Options exercised during the year 0.25 Options expired during the year 0.25 Options forfeited/cancelled during the year 0.45 Option price Number of options Expiry date per share 2013 June 30, 2014 $ 0.25 175,000 June 15, 2015 $ 0.20 35,000 October 2, 2015 $ 0.42 200,000 October 25, 2016 $ 0.45 1,100,000 TOTAL 1,510,000 Weighted average exercise price: Options outstanding at end of year $ 0.42 Options granted during the year $ - Options exercised during the year $ - Options expired during the year $ 0.50 Options forfeited/cancelled during the year $ - The share options outstanding at the end of the year had a weighted average remaining contractual life as follows: 2014 2013 (Years) (Years) Total outstanding options 4.0 2.6 Total exercisable options 4.0 2.6

STOCK PURCHASE WARRANTS

STOCK PURCHASE WARRANTS	12 Months Ended
	Nov. 30, 2014
STOCK PURCHASE WARRANTS [Text Block]	7. STOCK PURCHASE WARRANTS Year ended November 30, 2014 On August 6, 2014, the Company issued $1,398,592 (CAD $1,549,000) face value 12% convertible debentures with a term to August 6, 2017 (the “Maturity Date”). At any time while the debentures are outstanding, the holder has the option to convert the outstanding principal of the debentures into common shares of the Company at a fixed conversion price of CAD $0.50 per share. In connection with the financing, the Company issued warrants to placement agents to purchase 151,900 shares of common stock at an exercise price of US $0.45 (CAD $0.50) per share. These warrants expire on August 5, 2016. The relative fair value allocated to warrants and credited to additional paid in capital was $33,583 Year ended November 30, 2013 On January 30, 2013, the Company issued a $199,342 (CAD $200,000) 6% convertible bridge loan with a term to July 30, 2013 issuance of the bridge loan, the Company issued detachable warrants to purchase 100,000 shares of the Company’s common stock at CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $24,246 (see note 15). On March 14, 2013, the Company issued a $97,456 (CAD $100,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 50,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $11,269 (see note 15) On April 12, 2013, the Company issued a $197,355 (CAD $200,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 100,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $20,502 (see note 15) On May 14, 2013, the Company issued a $147,812 (CAD $150,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 75,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The relative fair value allocated to warrants and credited to additional paid in capital was $21,520 (see note 15) On August 27, 2013, the Company completed an initial public offering to raise gross proceeds of $3,794,280 (CAD $3,993,980) through the issuance of 9,984,950 Common Shares at a price of $0.38 (CAD$0.40) per Common Share (the “Issue Price”). The Company incurred expenses of $724,580 (CAD $734,565) to raise the capital which included a fee of CAD $80,000 paid to a former director and CEO in accordance with the terms of an agreement regarding escrow of shares and a cash commission of CAD$359,458 paid to the Agent. In addition the Company granted warrants to purchase up to 898,645 Common Shares to the Agent and members of its selling group. The warrants entitle the Agent and members of its selling group to purchase Common Shares at a price of CAD$0.40 (US $0.38) per Common Share until August 27, 2015. Number of Warrants Exercise Expiry Granted Prices Date $ Outstanding at November 30, 2012 and average exercise price 4,319,000 0.19 Granted in year 2013 100,000 0.47 1/30/2015 Granted in year 2013 50,000 0.47 3/14/2015 Granted in year 2013 100,000 0.47 4/12/2015 Granted in year 2013 75,000 0.47 5/14/2015 Granted in year 2013 898,645 0.38 8/27/2015 Exercised - - Forfeited - - Expired - - Cancelled - - Outstanding at November 30, 2013 and average exercise price 5,542,645 0.23 Granted in year 2014 151,900 0.45 8/5/2016 Exercised - - Forfeited - - Expired (850,000 ) 0.25 Expired (50,000 ) 0.25 Cancelled - - Outstanding at November 30, 2014 and average exercise price 4,794,545 0.24 Exercisable at November 30, 2014 4,794,545 0.24 Exercisable at November 30, 2013 5,542,645 0.23 The warrants outstanding at the end of the year had a weighted average remaining contractual life as follows: 2014 2013 (Years) (Years) Total outstanding warrants 0.9 1.6 Total exercisable warrants 0.9 1.6

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	12 Months Ended
	Nov. 30, 2014
RELATED PARTY TRANSACTIONS [Text Block]	8. RELATED PARTY TRANSACTIONS The following transactions are in the normal course of operations and are measured at the exchange amount, which is the amount of consideration established and agreed to by the related parties. Year ended November 30, 2014 The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $248,439 as management fees for payment to its two directors and expensed a total of $6,700 as automobile allowance. In addition, the Company reimbursed $114,137 to directors and officers for travel and entertainment expenses incurred for the Company . On May 9, 2014, the board of directors granted options to one director to acquire a total of 600,000 common shares. These options were issued at an exercise price of $0.32 (CAD $0.35) per share and vest immediately with an expiry term of five years. The Company expensed stock based compensation cost of $140,573 for these options. On September 11, 2014, the board of directors granted options to directors to acquire a total of 1,800,000 common shares. These options were issued at an exercise price of $0.36 (CAD $0.40) per share and vest immediately with an expiry date of September 10, 2019. The Company expensed stock based compensation cost of $508,020 for these options issued to directors of the Company. The Company expensed $38,700 for services provided by the CFO of the Company and $230,890 for services provided by a Company in which the Chief Operating Officer has an interest. Year ended November 30, 2013 The directors were compensated as per their consulting agreements with the Company. The Company expensed a total of $296,700 as management fees for payment to its three directors and expensed a total of $7,200 as automobile allowance. In addition, the Company reimbursed $164,118 to directors and officers for travel and entertainment expenses incurred for the Company . On March 14, 2013, the Company issued a $97,456 (CAD $100,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”) to a director. The holder has the option at any time prior to the maturity date to demand the payment of principal and interest (the “Demand Date”). Therefore, the principal amount of the note and interest is payable at the earlier of the demand date or the maturity date. In the event the holder demands payment, the Company has ten days to make payment. In the event the Company does not make payment within the ten day period, the holder has the option to convert the outstanding principal, interest, and top-up mechanism into common stock. The conversion price of the note is equal to the twenty day moving average of the trading market price on the date of conversion (“variable conversion price”). The holder is entitled to the maximum allowable discount. As a top-up mechanism, on or before the maturity date, the Company is required to pay the holder $5,847. This top-up mechanism is payable in addition the 6% interest due on the note. In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 50,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. On September 16, 2013, the Company repaid the bridge loan ($97,456), accrued interest ($2,980), and top-up mechanism ($5,847) totaling $106,283 in full. As a result of the repayment, a gain on extinguishment of debt amounting to $11,107 was recorded. The Company expensed $58,530 for services provided by the CFO of the Company and $240,000 for services provided by a Company in which the Chief Operating Officer has an interest.

PLANT AND EQUIPMENT

PLANT AND EQUIPMENT	12 Months Ended
	Nov. 30, 2014
PLANT AND EQUIPMENT [Text Block]	9. PLANT AND EQUIPMENT Plant and equipment are recorded at cost less accumulated depreciation. November November 30, 2014 30, 2013 Accumulated Accumulated Cost Depreciation Cost Depreciation $ $ $ $ Computer equipment 37,573 33,159 37,573 31,267 Furniture and fixtures 18,027 15,212 18,027 14,006 Leasehold Improvements 23,721 13,151 23,721 10,057 Moulds 209,515 83,138 171,890 43,74 288,836 144,660 251,211 99,074 Net carrying amount $ 144,176 $ 152,137 Depreciation expense $ 45,586 $ 38,130

INCOME TAXES

INCOME TAXES	12 Months Ended
	Nov. 30, 2014
INCOME TAXES [Text Block]	10. INCOME TAXES The Company has non-capital losses of approximately $15,831,371 (2013: $14,371,847) available, which can be applied against future taxable income and which expire as follows: 2025 $ 188,494 2026 609,991 2027 1,731,495 2028 3,174,989 2029 2,792,560 2030 2,044,857 2031 854,218 2032 1,073,610 2033 1,410,557 2034 1,950,600 $ 15,831,371 The reconciliation of income taxes at statutory income tax rates to the income tax expense is as follows: November November 30, 2014 30, 2013 Loss before income taxes $ (2,722,412 ) $ (2,024,211 ) Applicable statutory tax rate 35.0% 35.0% Income tax recovery at statutory rate (952,844 ) (708,474 ) Permanent differences 270,134 60,566 Tax benefit not recognized 682,710 647,908 Income taxes – current and deferred $ - $ - Reconciliation of statutory tax rate to the effective income tax rate is as follows: Federal statutory income tax rate 35.0% Deferred tax asset valuation allowance (35.0)% Deferred tax asset components as of November 30, 2014 and 2013 are as follows: 2014 2013 Operating losses available to offset future income-taxes $ 15,831,371 $ 14,371,847 Expected Income tax recovery at statutory rate of 35% (2012: 35.0% $ (5,540,980 ) $ (5,030,146 ) Undeducted share issue costs - (239,958 ) Valuation Allowance $ 5,540,980 $ 5,270,104 Net deferred tax assets - - As the company has not earned significant revenues, it has provided a 100 per cent valuation allowance on the net deferred tax asset as of November 30, 2014 and 2013. Management believes the Company has no uncertain tax position

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Nov. 30, 2014
COMMITMENTS AND CONTINGENCIES [Text Block]	11. COMMITMENTS AND CONTINGENCIES COMMITMENTS a) Consulting agreements: The directors of the Company executed consulting agreements with the company on the following terms: Effective January 1, 2013, SDI executed a two year agreement with a company in which a director, Allen Ezer, has an interest. The agreement was extended for a period of two years ending December 31, 2016 at a monthly remuneration of CAD $8,925.Either party may terminate the consulting agreement by giving 90 days written notice. In the event of termination without cause due to change in control brought out by sale, lease, merger or transfer, the Company is obligated to pay severance of 12 months fees at current rate at time of change in control. Agreement with the Chief Executive Officer Greg Sullivan to pay compensation of CAD$12,000 per month, with an annual 5% increase and a car allowance of CAD$600 per month. The agreement expires on December 31, 2016. In the event of termination without cause, the Company is obligated to pay two times the then monthly compensation and by continuing the then benefits coverage for a period of 2 years. The monthly remuneration will increase with accomplishment of milestones. The agreement may be terminated with mutual consent or by the Chief Executive Officer giving three weeks’ notice. Effective October 1, 2014, SDI executed a renewal agreement with a company in which the Chief Operating Officer Dean Thrasher has an interest in, for a period which expires on December 31, 2017 for services rendered. The total consulting fees are estimated at CAD$864,000 for the three year period. In the event of termination without cause due to change in control brought out by sale, lease, merger or transfer, the Company is obligated to pay severance of 18 months fees at current rate at time of change in control. SDI paid cash and expensed $230,892 during the year ended November 30, 2014. The company may also accept common shares in lieu of cash. As of November 30, 2014, the company has not exercised its right to accept this compensation in shares. Effective January 1, 2013, SDI executed an agreement with a non-related consultant to pay compensation of CAD $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year and was renewed for an additional period of one year. Either party may terminate the consulting agreement by giving 30 days written notice. Subsequent to the year, the Company extended this agreement for four months at a rate of $5,000 per month, expiring April 30, 2015. Effective January 1, 2013, SDI executed an agreement with another non-related consultant to pay compensation of $7,000 per month. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement is for a period of one year and was renewed for an additional period of one year. Either party may terminate the consulting agreement by giving 30 days written notice. Subsequent to the year, the Company terminated this agreement (see subsequent event note 18) Effective November 1, 2013, SDI executed an agreement with a non-related consultant to pay compensation of $5,000 per month. The consultant has agreed to provide corporate market advisory services. The agreement is for a period of a minimum of three months and will continue unless otherwise terminated by either party by giving 30 days written notice. Effective April 2014, SDI executed an agreement with a non-related consultant to set up its social media sites and optimization of search engines for the Company, at a start up fee for CAD$3,000 (Phase 1) and payment of CAD$1,500 per month and issued 100,000 stock options at $0.32 (CAD$0.35) when Phase 2 of the project was implemented (refer to note 6). Effective August 2014, SDI executed an agreement with a non-related consultant to pay compensation of $5,500 per month for the first 5 months and $5,000 from sixth month to end of the term. The consultant is to assist with sales initiatives, demos and participate in trade shows. The agreement unless renewed by mutual consent expires December 31, 2015. On renewal, there will an annual increase of 4.5% effective January 1, 2016. The consultant is also entitled to a 5% cash commission for all completed direct sales to end users and a 2% cash commission for all completed indirect sales. The Company granted 50,000 stock options to the consultant on July 25, 2014 and has agreed to grant 25,000 stock options for every 5,000 rounds sold domestically to a maximum of an additional 150,000 options. Either party may terminate the consulting agreement by giving 30 days written notice. b) The Company has commitments for leasing office premises in Oakville, Ontario, Canada to April 30, 2018 at a monthly rent of $5,593 (CAD $6,399). c) The Company has commitments for leasing office premises in Tampa, Florida, USA to June 30, 2015 at a monthly rent of $1,418. CONTINGENCIES In November of 2013, a former officer filed a law suit against the Company in the Ontario Superior Court of Justice (Province of Ontario) seeking, among other things, $60,000 in damages for wrongful dismissal, damages of $35,000 on account of vacation pay and damages to be determined for out of pocket expenses, breach of contract, unjust enrichment and loss of business opportunity. Subsequent to the year, the Company and the former officer executed a settlement agreement at CAD $15,000 (see note 18).

EXCLUSIVE SUPPLY AND TEAMING AG

EXCLUSIVE SUPPLY AND TEAMING AGREEMENT	12 Months Ended
	Nov. 30, 2014
EXCLUSIVE SUPPLY AND TEAMING AGREEMENT [Text Block]	12. EXCLUSIVE SUPPLY AND TEAMING AGREEMENT The Company entered into a Development, Supply and Manufacturing Agreement with the BIP Manufacturer on July 25, 2012. This Agreement provides the Company to order and purchase only from the BIP Manufacturer certain 40MM assemblies and components for use by the Company to produce less-lethal and training projectiles as described in the Agreement. The Agreement is for a term of five years with an automatic extension for an additional year if neither party has given written notice of termination prior to the end of the five year period. The Company and a division of Abrams Airborne Manufacturing Inc. (AAMI), namely Milkor USA (MUSA), agreed to partner for a joint cross-selling / marketing initiative. This arrangement allows both companies to leverage existing and future sales channels by offering a comprehensive, full-package of Milkor USA’s 40mm Multi-Shot Grenade Launchers in conjunction with SDI’s 40mm Less-Lethal ammunition product-line to end-users globally.

SEGMENT DISCLOSURES

SEGMENT DISCLOSURES	12 Months Ended
	Nov. 30, 2014
SEGMENT DISCLOSURES [Text Block]	13. SEGMENT DISCLOSURES The Company, after reviewing its reporting systems, has determined that it has one reportable segment and geographic segment. The Company’s operations are all related to the wireless electric ammunition, as well as its blunt impact projectile. All assets of the business are located in Canada except for accounts receivable for $3,828 (2013: $20,351), inventory $120,246 (2013: $nil) and plant and equipment comprising of moulds for $126,377 (2013: $128,146) which is located in the United States of America.

CONVERTIBLE DEBENTURES AND DEFE

CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS	12 Months Ended
	Nov. 30, 2014
CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS [Text Block]	14. CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS Year ended November 30, 2014 $1,398,592 (CAD $1,549,000) Convertible Debentures On August 6, 2014, the Company issued $1,398,592 (CAD $1,549,000) face value 12% convertible debentures with a term to August 6, 2017 (the “Maturity Date”). At any time while the debentures are outstanding, the holder has the option to convert the outstanding principal of the debentures into common shares of the Company at a fixed conversion price of CAD $0.50 per share. At any time after February 6, 2015, the Company has the right to force the conversion of the debentures into common shares at a price of at least CAD$0.65 per common share for a period of at least 20 consecutive trading days. If the common shares do not trade on any trading day and the bid price of the common Shares is CAD $0.65 or greater, the common shares shall be deemed to have traded at a price of at least CAD $0.65 on that trading day. Additionally, the Company has the right to redeem the debentures, in whole or in part, (a) during the 12 months ending August 6, 2015, at a premium of 15% to the principal amount being redeemed plus any accrued interest, (b) during the 12 months ending August 6, 2016, at a premium of 5% to the principal amount being redeemed plus any accrued interest, (c) during the 12 months ending August 6, 2017, at a premium of 2% to the principal amount being redeemed plus any accrued interest. In connection with the financing, the Company issued warrants to placement agents to purchase 151,900 shares of common stock at an exercise price of CAD $0.50 per share. Additionally, the Company incurred $157,293 (CAD $174,209) in financing fees. The Company has evaluated the terms and conditions of the convertible debentures and placement agent warrants under the guidance of ASC 815. The conversion feature met the definition of conventional convertible for purposes of applying the conventional convertible exemption. The definition of conventional contemplates a fixed number of shares issuable under the arrangement. The instrument was convertible into a fixed number of shares and there were no down round anti-dilution protection features contained in the contracts. The Company was required to consider whether the hybrid contract embodied a beneficial conversion feature (“BCF”). The debentures did not result in a BCF because the conversion price was not in the money on the inception date. There were no terms or features contained in the warrant agreement that would preclude the warrants from achieving equity classification. The following table reflects the allocation of the purchase on the financing date: Convertible Debentures Face Value $ $1,398,342 Proceeds $ (1,279,773 ) Deferred financing costs (190,876 ) Paid in capital (warrants) 33,583 Prepaid expenses 16,681 Accrued expenses 21,793 Convertible debentures 1,398,592 The warrants were valued at $33,583 and were recorded as a component of deferred financing costs. Interest expense related to the debentures amounted to $73,540 for the period ended November 30, 2014. Of the $73,540, $53,338 related to accrued interest and the remaining $20,202 related to the amortization of deferred financing costs. Year ended November 30, 2013 During the six month period ended May 31, 2013 the Company issued 1,801,480 common shares for conversion of convertible debentures having face value of $500,000 and accrued interest of $40,444. The total debt for $540,444 was converted into 1,801,480 common shares at $0.30 per share. On August 27, 2013, upon completion of the Offering, $700,000 face value of convertible debentures along with $97,716 of interest was converted to 2,297,044 Common Shares, resulting in the discharge of those debentures. In addition, the Company repaid the balance of $30,000 face value of convertible debenture not converted along with accrued interest of $3,877 and also repaid interest of $3,024 not converted to common shares. This resulted in the complete discharge of all convertible debt.

CONVERTIBLE BRIDGE LOANS

CONVERTIBLE BRIDGE LOANS	12 Months Ended
	Nov. 30, 2014
CONVERTIBLE BRIDGE LOANS [Text Block]	15. CONVERTIBLE BRIDGE LOANS Year ended November 30, 2013: a) $199,342 (CAD $200,000) Convertible Bridge Loan On January 30, 2013, the Company issued a $199,342 (CAD $200,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). The holder has the option at any time prior to the maturity date to demand the payment of principal and interest (the “Demand Date”). Therefore, the principal amount of the note and interest is payable at the earlier of the demand date or the maturity date. In the event the holder demands payment, the Company has ten days to make payment. In the event the Company does not make payment within the ten day period, the holder has the option to convert the outstanding principal, interest, and top-up mechanism into common stock. The conversion price of the note is equal to the twenty day moving average of the trading market price on the date of conversion (“variable conversion price”). The holder is entitled to the maximum allowable discount. As a top-up mechanism, on or before the maturity date, the Company is required to pay the holder $11,961. This top-up mechanism is payable in addition the 6% interest due on the note. In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 100,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The Company evaluated the terms and conditions of the convertible bridge loan and detachable warrants under the guidance of ASC 815. The following table reflects the allocation on the financing date: Convertible Bridge Loans Face Value $ 199,342 Proceeds $ (199,342 ) Embedded conversion feature 159,268 Paid in capital (warrants) 24,246 Convertible bridge loans 15,828 On September 16, 2013, the holder converted the bridge loan ($199,342), accrued interest ($7,504), and top-up mechanism ($11,961) totaling $218,807 into 736,078 shares of common stock. Prior to the conversion, the discount of $183,514 was amortized up to face value using the effective interest method. b) $97,456 (CAD $100,000) Convertible Bridge Loan On March 14, 2013, the Company issued a $97,456 (CAD $100,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). The holder has the option at any time prior to the maturity date to demand the payment of principal and interest (the “Demand Date”). Therefore, the principal amount of the note and interest is payable at the earlier of the demand date or the maturity date. In the event the holder demands payment, the Company has ten days to make payment. In the event the Company does not make payment within the ten day period, the holder has the option to convert the outstanding principal, interest, and top-up mechanism into common stock. The conversion price of the note is equal to the twenty day moving average of the trading market price on the date of conversion (“variable conversion price”). The holder is entitled to the maximum allowable discount. As a top-up mechanism, on or before the maturity date, the Company is required to pay the holder $5,847. This top-up mechanism is payable in addition the 6% interest due on the note. In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 50,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The Company has evaluated the terms and conditions of the convertible bridge loan and detachable warrants under the guidance of ASC 815. The following table reflects the allocation on the financing date: Convertible Bridge Loans Face Value $ 97,456 Proceeds $ (97,456 ) Embedded conversion feature 56,477 Paid in capital (warrants) 11,269 Convertible bridge loans 29,710 On September 16, 2013, the Company repaid the bridge loan ($97,456), accrued interest ($2,980), and top-up mechanism ($5,847) totaling $106,283 in full. As a result of the repayment, a gain on extinguishment of debt amounting to $11,107 was recorded. Prior to the repayment, the discount of $67,746 was amortized up to face value using the effective interest method. c) $197,355 (CAD $200,000) Convertible Bridge Loan On April 12, 2013, the Company issued a $197,355 (CAD $200,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). The holder has the option at any time prior to the maturity date to demand the payment of principal and interest (the “Demand Date”). Therefore, the principal amount of the note and interest is payable at the earlier of the demand date or the maturity date. In the event the holder demands payment, the Company has ten days to make payment. In the event the Company does not make payment within the ten day period, the holder has the option to convert the outstanding principal, interest, and top-up mechanism into common stock. The conversion price of the note is equal to the twenty day moving average of the trading market price on the date of conversion (“variable conversion price”). The holder is entitled to the maximum allowable discount. As a top-up mechanism, on or before the maturity date, the Company is required to pay the holder $11,841. This top-up mechanism is payable in addition the 6% interest due on the note. In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 100,000 shares of the Company’s common stock. The warrants have an exercise price of $0.50 per share and a time to expiration of two years. The Company has evaluated the terms and conditions of the convertible bridge loan and detachable warrants under the guidance of ASC 815. The following table reflects the allocation on the financing date: Convertible Bridge Loans Face Value $ 197,355 Proceeds $ (197,355 ) Embedded conversion feature 105,423 Paid in capital (warrants) 20,502 Convertible bridge loans 71,430 On September 16, 2013, the Company repaid the bridge loan ($197,355), accrued interest ($5,093), and top-up mechanism ($11,841) totaling $214,289 in full. As a result of the repayment, a gain on extinguishment of debt amounting to $22,394 was recorded. Prior to the repayment, the discount of $125,925 was amortized up to face value using the effective interest method. d) $147,812 (CAD $150,000) Convertible Bridge Loan On May 14, 2013, the Company issued a $147,812 (CAD $150,000) 6% convertible bridge loan with a term to July 30, 2013 (the “Maturity Date”). The holder has the option at any time prior to the maturity date to demand the payment of principal and interest (the “Demand Date”). Therefore, the principal amount of the note and interest is payable at the earlier of the demand date or the maturity date. In the event the holder demands payment, the Company has ten days to make payment. In the event the Company does not make payment within the ten day period, the holder has the option to convert the outstanding principal, interest, and top-up mechanism into common stock. The conversion price of the note is equal to the twenty day moving average of the trading market price on the date of conversion (“variable conversion price”). The holder is entitled to the maximum allowable discount. As a top-up mechanism, on or before the maturity date, the Company is required to pay the holder $8,869. This top-up mechanism is payable in addition the 6% interest due on the note. In connection with the issuance of the bridge loan, the Company issued detachable warrants to purchase 75,000 shares of the Company’s common stock. The warrants have an exercise price of CAD$0.50 per share and a time to expiration of two years. The Company has evaluated the terms and conditions of the convertible bridge loan and detachable warrants under the guidance of ASC 815. The following table reflects the allocation on the financing date: Convertible Bridge Loans Face Value $ 147,812 Proceeds $ (147,812 ) Embedded conversion feature 101,422 Paid in capital (warrants) 21,520 Convertible bridge loans 24,870 On September 16, 2013, the holder converted the bridge loan ($147,812), accrued interest ($3,037), and top-up mechanism ($8,869) totaling $159,718 into 537,300 shares of common stock. Prior to the conversion, the discount of $122,942 was amortized up to face value using the effective interest method.

DERIVATIVE FINANCIAL INSTRUMENT

DERIVATIVE FINANCIAL INSTRUMENTS	12 Months Ended
	Nov. 30, 2014
DERIVATIVE FINANCIAL INSTRUMENTS [Text Block]	16. DERIVATIVE FINANCIAL INSTRUMENTS Year ended November 30, 2013 Derivative Liabilities The convertible bridge loans as described in Note 15 contained embedded conversion features that embodied terms and features that required the instruments to be bifurcated and carried as derivative liabilities. However, as of the reporting date these derivative financial instruments were either fully converted or fully repaid. As a result, there are no derivative financial instruments as of November 30, 2013. The following table illustrates the amounts that were reflected in the earnings related to our derivatives for the year ended November 30, 2013: Year Ended Derivative income (expense): November 30, 2013 $199,342 face value convertible bridge loan (embedded conversion feature) $ 136,402 $97,456 face value convertible bridge loan (embedded conversion feature) 45,370 $197,355 face value convertible bridge loan (embedded conversion feature) 83,029 $147,812 face value convertible bridge loan (embedded conversion feature) 84,731 Total derivative income $ 349,532

INVENTORY

INVENTORY	12 Months Ended
	Nov. 30, 2014
INVENTORY [Text Block]	17. INVENTORY Inventory as of November 30, 2014 consist of finished goods of Blunt Impact Projectiles 40mm for $120,246 which are held at the BIP manufacturer.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	12 Months Ended
	Nov. 30, 2014
SUBSEQUENT EVENTS [Text Block]	18. SUBSEQUENT EVENTS In December, 2014, SDI terminated the agreement executed with a non-related consultant to pay compensation of $7,000 per month. The Company and a former officer executed a settlement agreement to settle a lawsuit filed by the said officer seeking damages for wrongful dismissal, vacation pay, out of pocket expenses, breach of contract and loss of business opportunity. The Company agreed to pay CAD$15,000 in settlement. (See note 11 on Contingencies)

Summary of Significant Accoun25

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Nov. 30, 2014
Use of Estimates [Policy Text Block]	a) Use of Estimates These financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America. As the precise determination of assets and liabilities, and revenues and expenses, depends on future events, the preparation of financial statements for any period necessarily involves the use of estimates. Actual amounts may differ from these estimates. Significant estimates include accruals, valuation allowance for deferred tax assets, estimates for calculation of stock based compensation, estimating the useful life of its plant and equipment and accounting for conversion features on convertible debt transactions.
Income Taxes [Policy Text Block]	b) Income Taxes The Company accounts for income taxes under FASB Codification Topic 740-10-25 (“ASC 740-10- 25”). Under ASC 740-10-25, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740- 10-25, the effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company provides a valuation allowance for deferred tax assets for which it does not consider realization of such assets likely. The Company did not incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The Company is subject to U.S federal jurisdiction income tax examinations for the tax years 2008 through 2013. In addition, the Company is subject to state and local income tax examinations for the tax years 2008 through 2013.
Revenue Recognition [Policy Text Block]	c) Revenue Recognition The Company’s revenue recognition policies follow common practice in the manufacturing industry. The Company records revenue when it is realized, or realizable and earned. The Company considers revenue to be realized, or realizable and earned, when the following revenue recognition requirements are met: persuasive evidence of an arrangement exists; the products or services have been accepted by the customer via delivery or installation acceptance; the sales price is fixed or determinable; and collectability is probable. For product sales, the Company determines that the earnings process is complete when title, risk of loss and the right to use product has transferred to the customer.
Loss Per Share [Policy Text Block]	d) Loss Per Share Basic loss per share is computed by dividing net loss by the weighted average number of common shares outstanding for the year. Diluted loss per share is computed by dividing net loss by the weighted average number of common shares outstanding plus common stock equivalents (if dilutive) related to stock options and warrants for each year. There were no common equivalent shares outstanding at November 30, 2014 and 2013 that have been included in dilutive loss per share calculation as the effects would have been anti-dilutive. At November 30, 2014, there were 3,360,000 options and 4,794,545 warrants outstanding, which were convertible into equal number of common shares of the Company. At November 30, 2013, there were 1,510,000 options and 5,542,645 warrants outstanding, which were convertible into equal number of common shares of the Company.
Cash and cash equivalents [Policy Text Block]	e) Cash and cash equivalents Cash and cash equivalents include cash on hand, amounts due from banks, and any other highly liquid investments with a maturity of three months or less. The carrying amounts approximate fair values because of the short maturity of those instruments.
Research and Product Development [Policy Text Block]	f) Research and Product Development Research and Product Development costs, other than capital expenditures but including acquired research and product development costs, are charged against income in the period incurred.
Stock-Based Compensation [Policy Text Block]	g) Stock-Based Compensation All awards granted to employees and non-employees after November 30, 2005 are valued at fair value by using the Black-Scholes option pricing model and recognized on a straight line basis over the service periods of each award. The Company accounts for equity instruments issued in exchange for the receipt of goods or services from other than employees using the estimated fair market value of the consideration received or the estimated fair value of the equity instruments issued, whichever is more reliably measurable. The value of equity instruments issued for consideration other than employee services is determined on the earlier of a performance commitment or completion of performance by the provider of goods or services. As of November 30, 2014 there was $nil of unrecognized expense related to non-vested stock-based compensation arrangements granted. The total stock-based compensation expense relating to all employees and non employees for the years ended November 30, 2014 and 2013 was $751,610 and $Nil respectively.
Foreign Currency [Policy Text Block]	h) Foreign Currency The parent Company maintains its books and records in U.S. dollars which is its functional and reporting currency.The Company’s operating subsidiary is a foreign private company and maintains its books and records in Canadian dollars (the functional currency). The subsidiary’s financial statements are converted to US dollars for consolidation purposes. The translation method used is the current rate method, where the functional currency is the foreign currency. Under the current rate method all assets and liabilities are translated at the current rate, stockholders’ equity accounts are translated at historical rates and revenues and expenses are translated at average rates for the year. Due to the fact that items in the financial statements are being translated at different rates according to their nature, a translation adjustment is created. This translation adjustment has been included in Accumulated Other Comprehensive Income (Loss).
Comprehensive loss [Policy Text Block]	i) Comprehensive loss Comprehensive loss includes all changes in equity (net assets) during a period from non- owner sources. Examples of items to be included in comprehensive loss, which are excluded from net loss, include foreign currency translation adjustments and unrealized gains and losses on available-for-sale securities.
Financial Instruments [Policy Text Block]	j) Financial Instruments The Company’s financial instruments consist of cash and cash equivalents, accounts receivable and accounts payable and accrued liabilities. The Company follows ASC 820-10, “Fair Value Measurements and Disclosures” (ASC 820-10), which among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is an exit price, representing the amount that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, a three-tier fair value hierarchy has been established, which prioritizes the inputs used in measuring fair value as follows: • Assets that are generally included in this category are cash and cash equivalents comprised of money market funds, restricted cash and short-term investments. • • Assets and liabilities measured at fair value as of November 30, 2014 and 2013 are classified below based on the three fair value hierarchy tiers described above: Carrying Fair Value Value November 30, 2014: Cash and cash equivalents $ 1,085,006 $ 1,085,006 Accounts receivable $ 7,393 $ 7,393 Accounts payable and accrued liabilities $ 161,405 $ 161,405 Convertible debentures $ 1,398,592 $ 1,398,592 Carrying Fair Value Value November 30, 2013: Cash and cash equivalents $ 1,842,149 $ 1,842,149 Accounts receivable $ 20,351 $ 20,351 Accounts payable and accrued liabilities $ 106,529 $ 106,529 Cash and cash equivalents have been measured using Level 1 of the Fair Value Hierarchy. Foreign exchange risk: The Company’s subsidiary conducts its operating activities in Canadian dollars. The Company is therefore subject to gains or losses due to fluctuations in Canadian currency relative to the US dollar. Liquidity risk The Company’s exposure to liquidity risk is dependent on the ability to raise funds to meet commitments and to sustain operations. The company controls its liquidity risk by managing working capital and cash flows.
Impairment of Long-lived Assets [Policy Text Block]	k) Impairment of Long-lived Assets Long-lived assets to be held and used are analyzed for impairment whenever events or changes in circumstances indicate that the related carrying amounts may not be recoverable. The Company evaluates at each balance sheet date whether events and circumstances have occurred that indicate possible impairment. If there are indications of impairment, the Company uses future undiscounted cash flows of the related asset or asset group over the remaining life in measuring whether the assets are recoverable. In the event such cash flows are not expected to be sufficient to recover the recorded asset values, the assets are written down to their estimated fair value.
Concentration of Credit Risk [Policy Text Block]	l) Concentration of Credit Risk The Company does not have significant off-balance sheet risk or credit concentration.
Convertible Debt Instruments [Policy Text Block]	m) Convertible debt instruments The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 Debt with Conversion and Other Options
Intellectual Property [Policy Text Block]	n) Intellectual Property Four patent applications, one for the electrical mechanism and the other three for the mechanical mechanism of the WEP40, have been filed by the Company with the U.S. Patent Office. The Company has been issued four patents. (a) Less-lethal Projectile: This issued patent relates to the Company’s distinctive collapsible ammunition head technology that absorbs kinetic energy of the projectile upon impact. The Corporation’s collapsible head is used in both the BIP and the WEP. (b) Electronic Circuitry for Incapacitating a Living Target: This issued patent relates to the electronic circuitry incapacitation system which forms part of the WEP. The patent describes an electronic circuit which provides an electrical incapacitation current to a living target. (c) Less-lethal Wireless Stun Projectile System for Immobilizing a Target by Neuro-Muscular Disruption: This issued patent describes the process by which the WEP operates with its attachment system to halt a target through a neuro-muscular-disruption system. (d) Autonomous Operation of a Less-lethal Projectile: This pending patent describes a motion sensing system within the WEP. The sensor will monitor movement of the target and enable the electrical output until the target is subdued. The electrical pulse is programmed for an exact time-frame to specifications of the user. The Company’s policy is to write off patent costs as they are incurred.
Plant and Equipment [Policy Text Block]	o) Plant and Equipment Plant and equipment are recorded at cost less accumulated depreciation. Depreciation is provided commencing in the month following acquisition using the following annual rate and method: Computer equipment 30% declining balance method Furniture and fixtures 30% declining balance method Leasehold Improvements Moulds straight line over period of lease 20% Straight line over 5 years
Inventories [Policy Text Block]	q) Recent Accounting Pronouncements In June 2014, the FASB issued ASU 2014-10, “Development Stage Entities (Topic 915): Elimination of Certain Financial Reporting Requirements” In August 2012, the FASB issued ASU 2012-03, Technical Amendments and Corrections to SEC Sections: Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin (SAB) No. 114, Technical Amendments Pursuant to SEC Release No. 33-9250, and Corrections Related to FASB Accounting Standards Update 2010-22 (SEC Update) In April 2014, the FASB issued ASU 2014-08, Presentation of Financial Statements (Topic 205) and Property, Plant, and Equipment (Topic 360): Reporting Discontinued Operations and Disclosures of Disposals of Components of an Entity , In May 2014, the FASB issued ASU 2014-09, Revenue from Contracts with Customers (Topic 606) In August 2014, the FASB issued ASU 2014-15 Presentation of Financial Statements—Going Concern (Subtopic 205-40): Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern On January 9, 2015, FASB issued ASU 2015-01, Income Statement- Extraordinary and Unusual Items (Subtopic 225-20): Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items. The ASU eliminates the concept of extraordinary items and the uncertainty in determining when an item is both unusual in nature and infrequent in occurrence This ASU is effective for years beginning after December 15, 2015, with early adoption permitted. The Company is currently assessing the impact of this guidance. Management does not believe that any other recently issued, but not yet effective accounting pronouncements, if adopted, would have a material effect on the accompanying financial statements.
Recent Accounting Pronouncements [Policy Text Block]	p) Inventories Inventories are valued at the lower of cost and net realizable value with cost being determined on the first-in, first-out basis for Blunt Impact Projectiles.

SUMMARY OF SIGNIFICANT ACCOUN26

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Depreciation Rate, Plant and Equipment [Table Text Block]	Computer equipment 30% declining balance method Furniture and fixtures 30% declining balance method Leasehold Improvements Moulds straight line over period of lease 20% Straight line over 5 years

ACCOUNTS PAYABLE AND ACCRUED 27

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	2014 2013 Accounts payable and accrued liabilities are comprised of the following: Trade payables $ 35,885 $ 48,494 Accrued liabilities-accrued interest $ 53,338 $ Accrued liabilities-other liabilities $ 72,182 $ 58,035 $ 161,405 $ 106,529

STOCK BASED COMPENSATION (Table

STOCK BASED COMPENSATION (Tables)	12 Months Ended
	Nov. 30, 2014	Nov. 30, 2013
Schedule of Share-based Compensation and Assumptions as of March 19, 2014 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 151.63% Market price of Company’s common stock on date of grant of options $ 0.16 Stock-based compensation cost $ 47,897
Schedule of Share-based Compensation and Assumptions as of May 9, 2014 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 205.42% Market price of Company’s common stock on date of grant of options $ 0.24 Stock-based compensation cost $ 140,573
Schedule of Share-based Compensation and Assumptions as of July 25, 2014 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 152.35% Market price of Company’s common stock on date of grant of options $ 0.28 Stock-based compensation cost $ 33,952
Schedule of Share-based Compensation and Assumptions as of September 11, 2014 [Table Text Block]	Risk free rate 2.00% Expected dividends 0% Forfeiture rate 0% Volatility 170.42% Market price of Company’s common stock on date of grant of options $ 0.30 Stock-based compensation cost $ 529,188
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Number of options 2014 2013 Outstanding, beginning of year 1,510,000 1,660,000 Granted 3,025,000 - Expired (125,000 ) (150,000 ) Exercised (50,000 ) - Forfeited (1,000,000 ) - Cancelled - - Outstanding, end of year 3,360,000 1,510,000 Exercisable, end of year 3,360,000 1,510,000
Schedule of Share-based Compensation, Stock Options [Table Text Block]	Option price Number of options Expiry date per share 2014 June 15, 2015 $ 0.20 35,000 October 2, 2015 $ 0.42 200,000 October 25, 2016 $ 0.45 100,000 March 18, 2017 $ 0.31 400,000 August 5, 2017 $ 0.32 150,000 May 18, 2019 $ 0.32 600,000 September 10, 2019 $ 0.36 1,875,000 TOTAL 3,360,000 Weighted average exercise price: Options outstanding at end of year $ 0.35 Options granted during the year 0.34 Options exercised during the year 0.25 Options expired during the year 0.25 Options forfeited/cancelled during the year 0.45	Option price Number of options Expiry date per share 2013 June 30, 2014 $ 0.25 175,000 June 15, 2015 $ 0.20 35,000 October 2, 2015 $ 0.42 200,000 October 25, 2016 $ 0.45 1,100,000 TOTAL 1,510,000 Weighted average exercise price: Options outstanding at end of year $ 0.42 Options granted during the year $ - Options exercised during the year $ - Options expired during the year $ 0.50 Options forfeited/cancelled during the year $ -
Share-based Compensation Arrangement by Share-based Payment Award, Remaining Contractual Term, Outstanding and Exercisable [Table Text Block]	2014 2013 (Years) (Years) Total outstanding options 4.0 2.6 Total exercisable options 4.0 2.6

STOCK PURCHASE WARRANTS (Tables

STOCK PURCHASE WARRANTS (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Stockholders' Equity Note, Warrants or Rights, Activity [Table Text Block]	Number of Warrants Exercise Expiry Granted Prices Date $ Outstanding at November 30, 2012 and average exercise price 4,319,000 0.19 Granted in year 2013 100,000 0.47 1/30/2015 Granted in year 2013 50,000 0.47 3/14/2015 Granted in year 2013 100,000 0.47 4/12/2015 Granted in year 2013 75,000 0.47 5/14/2015 Granted in year 2013 898,645 0.38 8/27/2015 Exercised - - Forfeited - - Expired - - Cancelled - - Outstanding at November 30, 2013 and average exercise price 5,542,645 0.23 Granted in year 2014 151,900 0.45 8/5/2016 Exercised - - Forfeited - - Expired (850,000 ) 0.25 Expired (50,000 ) 0.25 Cancelled - - Outstanding at November 30, 2014 and average exercise price 4,794,545 0.24 Exercisable at November 30, 2014 4,794,545 0.24 Exercisable at November 30, 2013 5,542,645 0.23
Schedule of Stockholders' Equity Note, Warrants or Rights, Weighted Average Remaining Contractual Term, Outstanding and Exercisable [Table Text Block]	2014 2013 (Years) (Years) Total outstanding warrants 0.9 1.6 Total exercisable warrants 0.9 1.6

PLANT AND EQUIPMENT (Tables)

PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Property, Plant and Equipment [Table Text Block]	November November 30, 2014 30, 2013 Accumulated Accumulated Cost Depreciation Cost Depreciation $ $ $ $ Computer equipment 37,573 33,159 37,573 31,267 Furniture and fixtures 18,027 15,212 18,027 14,006 Leasehold Improvements 23,721 13,151 23,721 10,057 Moulds 209,515 83,138 171,890 43,74 288,836 144,660 251,211 99,074 Net carrying amount $ 144,176 $ 152,137 Depreciation expense $ 45,586 $ 38,130

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Nov. 30, 2014
Summary of Tax Credit Carryforwards [Table Text Block]	2025 $ 188,494 2026 609,991 2027 1,731,495 2028 3,174,989 2029 2,792,560 2030 2,044,857 2031 854,218 2032 1,073,610 2033 1,410,557 2034 1,950,600 $ 15,831,371
Schedule of Reconcilation of Income Tax Expense [Table Text Block]	November November 30, 2014 30, 2013 Loss before income taxes $ (2,722,412 ) $ (2,024,211 ) Applicable statutory tax rate 35.0% 35.0% Income tax recovery at statutory rate (952,844 ) (708,474 ) Permanent differences 270,134 60,566 Tax benefit not recognized 682,710 647,908 Income taxes – current and deferred $ - $ -
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	Federal statutory income tax rate 35.0% Deferred tax asset valuation allowance (35.0)%
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2014 2013 Operating losses available to offset future income-taxes $ 15,831,371 $ 14,371,847 Expected Income tax recovery at statutory rate of 35% (2012: 35.0% $ (5,540,980 ) $ (5,030,146 ) Undeducted share issue costs - (239,958 ) Valuation Allowance $ 5,540,980 $ 5,270,104 Net deferred tax assets - -

CONVERTIBLE DEBENTURES AND DE32

CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Convertible Debt [Table Text Block]	Convertible Debentures Face Value $ $1,398,342 Proceeds $ (1,279,773 ) Deferred financing costs (190,876 ) Paid in capital (warrants) 33,583 Prepaid expenses 16,681 Accrued expenses 21,793 Convertible debentures 1,398,592

CONVERTIBLE BRIDGE LOANS (Table

CONVERTIBLE BRIDGE LOANS (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Convertible Bridge Loans, Face Value $199,342 [Table Text Block]	Convertible Bridge Loans Face Value $ 199,342 Proceeds $ (199,342 ) Embedded conversion feature 159,268 Paid in capital (warrants) 24,246 Convertible bridge loans 15,828
Schedule of Convertible Bridge Loans, Face Value $97,456 [Table Text Block]	Convertible Bridge Loans Face Value $ 97,456 Proceeds $ (97,456 ) Embedded conversion feature 56,477 Paid in capital (warrants) 11,269 Convertible bridge loans 29,710
Schedule of Convertible Bridge Loans, Face Value $197,355 [Table Text Block]	Convertible Bridge Loans Face Value $ 197,355 Proceeds $ (197,355 ) Embedded conversion feature 105,423 Paid in capital (warrants) 20,502 Convertible bridge loans 71,430
Schedule of Convertible Bridge Loans, Face Value $147,812 [Table Text Block]	Convertible Bridge Loans Face Value $ 147,812 Proceeds $ (147,812 ) Embedded conversion feature 101,422 Paid in capital (warrants) 21,520 Convertible bridge loans 24,870

DERIVATIVE FINANCIAL INSTRUME34

DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Nov. 30, 2014
Schedule of Income from Derivatives [Table Text Block]	Year Ended Derivative income (expense): November 30, 2013 $199,342 face value convertible bridge loan (embedded conversion feature) $ 136,402 $97,456 face value convertible bridge loan (embedded conversion feature) 45,370 $197,355 face value convertible bridge loan (embedded conversion feature) 83,029 $147,812 face value convertible bridge loan (embedded conversion feature) 84,731 Total derivative income $ 349,532

NATURE OF OPERATIONS AND GOIN35

NATURE OF OPERATIONS AND GOING CONCERN (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)shares	CADshares
Nature Of Operations And Going Concern 1	$ 24,042,769
Nature Of Operations And Going Concern 2	7,237,381
Nature Of Operations And Going Concern 3	$ 160,000
Nature Of Operations And Going Concern 4 | shares	800,000	800,000
Nature Of Operations And Going Concern 5	$ 878,328
Nature Of Operations And Going Concern 6	910,000
Nature Of Operations And Going Concern 7	$ 649,750
Nature Of Operations And Going Concern 8 | shares	2,165,834	2,165,834
Nature Of Operations And Going Concern 9 | CAD		CAD 3,993,980
Nature Of Operations And Going Concern 10	$ 3,794,280
Nature Of Operations And Going Concern 11	9,984,950	9,984,950
Nature Of Operations And Going Concern 12 | CAD		CAD 0.40
Nature Of Operations And Going Concern 13	$ 0.38
Nature Of Operations And Going Concern 14	$ 1,398,592
Nature Of Operations And Going Concern 15 | CAD		CAD 1,549,000
Nature Of Operations And Going Concern 16	12.00%	12.00%
Nature Of Operations And Going Concern 17	$ 1,241,299

SUMMARY OF SIGNIFICANT ACCOUN36

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2014USD ($)shares
Summary Of Significant Accounting Policies 1	3,360,000
Summary Of Significant Accounting Policies 2	4,794,545
Summary Of Significant Accounting Policies 3	1,510,000
Summary Of Significant Accounting Policies 4	5,542,645
Summary Of Significant Accounting Policies 5 | $	$ 0
Summary Of Significant Accounting Policies 6 | $	751,610
Summary Of Significant Accounting Policies 7 | $	$ 0

CAPITAL STOCK (Narrative) (Deta

CAPITAL STOCK (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)$ / sharesshares	CADCAD / sharesshares
Capital Stock 1	100,000,000	100,000,000
Capital Stock 2	$ 0.001
Capital Stock 3 | shares	5,000,000	5,000,000
Capital Stock 4	$ 0.001
Capital Stock 5	$ 0.001
Capital Stock 6	50,000,000	50,000,000
Capital Stock 7 | shares	100,000,000	100,000,000
Capital Stock 8 | shares	5,000,000	5,000,000
Capital Stock 9	$ 0.001
Capital Stock 10 | shares	46,899,285	46,899,285
Capital Stock 11 | shares	46,849,285	46,849,285
Capital Stock 12 | shares	50,000	50,000
Capital Stock 13 | $ / shares	$ 0.25
Capital Stock 14 | shares	1,801,480	1,801,480
Capital Stock 15	$ 500,000
Capital Stock 16	40,444
Capital Stock 17	$ 3,794,280
Capital Stock 18 | CAD		CAD 3,993,980
Capital Stock 19	9,984,950	9,984,950
Capital Stock 20	$ 0.38
Capital Stock 21 | CAD		CAD 0.40
Capital Stock 22	$ 724,580
Capital Stock 23 | CAD		734,565
Capital Stock 24 | CAD		80,000
Capital Stock 25 | CAD		CAD 359,458
Capital Stock 26	898,645	898,645
Capital Stock 27 | CAD		CAD 0.40
Capital Stock 28	$ 0.38
Capital Stock 29	700,000
Capital Stock 30	$ 97,716
Capital Stock 31	2,297,044	2,297,044
Capital Stock 32	$ 199,342
Capital Stock 33 | CAD		CAD 200,000
Capital Stock 34	6.00%	6.00%
Capital Stock 35 | shares	100,000	100,000
Capital Stock 36 | CAD / shares		CAD 0.50
Capital Stock 37	$ 24,246
Capital Stock 38	$ 97,456
Capital Stock 39 | CAD		CAD 100,000
Capital Stock 40	6.00%	6.00%
Capital Stock 41 | shares	50,000	50,000
Capital Stock 42 | CAD / shares		CAD 0.50
Capital Stock 43	$ 11,269
Capital Stock 44	$ 197,355
Capital Stock 45 | CAD		CAD 200,000
Capital Stock 46	6.00%	6.00%
Capital Stock 47 | shares	100,000	100,000
Capital Stock 48 | CAD / shares		CAD 0.50
Capital Stock 49	$ 20,502
Capital Stock 50	$ 147,812
Capital Stock 51 | CAD		CAD 150,000
Capital Stock 52	6.00%	6.00%
Capital Stock 53 | shares	75,000	75,000
Capital Stock 54 | CAD / shares		CAD 0.50
Capital Stock 55	$ 21,520
Capital Stock 56	378,525
Capital Stock 57 | CAD / shares		CAD 0.30
Capital Stock 58	$ 33,501

STOCK BASED COMPENSATION (Narra

STOCK BASED COMPENSATION (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)shares	CAD / shares
Stock Based Compensation 1	1,000,000
Stock Based Compensation 2	2,250,000
Stock Based Compensation 3	4,500,000
Stock Based Compensation 4	5,000,000
Stock Based Compensation 5	150,000
Stock Based Compensation 6	400,000
Stock Based Compensation 7	400,000
Stock Based Compensation 8 | $	$ 0.31
Stock Based Compensation 9 | CAD / shares		CAD 0.35
Stock Based Compensation 10	600,000
Stock Based Compensation 11 | $	$ 0.32
Stock Based Compensation 12 | CAD / shares		0.35
Stock Based Compensation 13	150,000
Stock Based Compensation 14 | $	$ 0.32
Stock Based Compensation 15 | CAD / shares		0.35
Stock Based Compensation 16	1,875,000
Stock Based Compensation 17 | $	$ 0.36
Stock Based Compensation 18 | CAD / shares		CAD 0.40
Stock Based Compensation 19 | $	0
Stock Based Compensation 20 | $	$ 0

STOCK PURCHASE WARRANTS (Narrat

STOCK PURCHASE WARRANTS (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)shares	CADCAD / sharesshares
Stock Purchase Warrants 1	$ 1,398,592
Stock Purchase Warrants 2 | CAD		CAD 1,549,000
Stock Purchase Warrants 3	12.00%	12.00%
Stock Purchase Warrants 4 | CAD / shares		CAD 0.50
Stock Purchase Warrants 5 | shares	151,900	151,900
Stock Purchase Warrants 6	$ 0.45
Stock Purchase Warrants 7 | CAD / shares		CAD 0.50
Stock Purchase Warrants 8	33,583
Stock Purchase Warrants 9	$ 199,342
Stock Purchase Warrants 10 | CAD		CAD 200,000
Stock Purchase Warrants 11	6.00%	6.00%
Stock Purchase Warrants 12 | shares	100,000	100,000
Stock Purchase Warrants 13 | CAD / shares		CAD 0.50
Stock Purchase Warrants 14	$ 24,246
Stock Purchase Warrants 15	$ 97,456
Stock Purchase Warrants 16 | CAD		CAD 100,000
Stock Purchase Warrants 17	6.00%	6.00%
Stock Purchase Warrants 18 | shares	50,000	50,000
Stock Purchase Warrants 19 | CAD / shares		CAD 0.50
Stock Purchase Warrants 20	$ 11,269
Stock Purchase Warrants 21	$ 197,355
Stock Purchase Warrants 22 | CAD		CAD 200,000
Stock Purchase Warrants 23	6.00%	6.00%
Stock Purchase Warrants 24 | shares	100,000	100,000
Stock Purchase Warrants 25 | CAD / shares		CAD 0.50
Stock Purchase Warrants 26	$ 20,502
Stock Purchase Warrants 27	$ 147,812
Stock Purchase Warrants 28 | CAD		CAD 150,000
Stock Purchase Warrants 29	6.00%	6.00%
Stock Purchase Warrants 30 | shares	75,000	75,000
Stock Purchase Warrants 31 | CAD / shares		CAD 0.50
Stock Purchase Warrants 32	$ 21,520
Stock Purchase Warrants 33	$ 3,794,280
Stock Purchase Warrants 34 | CAD		CAD 3,993,980
Stock Purchase Warrants 35	9,984,950	9,984,950
Stock Purchase Warrants 36	$ 0.38
Stock Purchase Warrants 37 | CAD		CAD 0.40
Stock Purchase Warrants 38	$ 724,580
Stock Purchase Warrants 39 | CAD		734,565
Stock Purchase Warrants 40 | CAD		80,000
Stock Purchase Warrants 41 | CAD		CAD 359,458
Stock Purchase Warrants 42	898,645	898,645
Stock Purchase Warrants 43 | CAD		CAD 0.40
Stock Purchase Warrants 44	$ 0.38

RELATED PARTY TRANSACTIONS (Nar

RELATED PARTY TRANSACTIONS (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)shares	CADCAD / sharesshares
Related Party Transactions 1	$ 248,439
Related Party Transactions 2	6,700
Related Party Transactions 3	$ 114,137
Related Party Transactions 4 | shares	600,000	600,000
Related Party Transactions 5	$ 0.32
Related Party Transactions 6 | CAD / shares		CAD 0.35
Related Party Transactions 7	$ 140,573
Related Party Transactions 8 | shares	1,800,000	1,800,000
Related Party Transactions 9	$ 0.36
Related Party Transactions 10 | CAD / shares		CAD 0.40
Related Party Transactions 11	508,020
Related Party Transactions 12	38,700
Related Party Transactions 13	230,890
Related Party Transactions 14	296,700
Related Party Transactions 15	7,200
Related Party Transactions 16	164,118
Related Party Transactions 17	$ 97,456
Related Party Transactions 18 | CAD		CAD 100,000
Related Party Transactions 19	6.00%	6.00%
Related Party Transactions 20	$ 5,847
Related Party Transactions 21	6.00%	6.00%
Related Party Transactions 22 | shares	50,000	50,000
Related Party Transactions 23 | CAD / shares		CAD 0.50
Related Party Transactions 24	$ 97,456
Related Party Transactions 25	2,980
Related Party Transactions 26	5,847
Related Party Transactions 27	106,283
Related Party Transactions 28	11,107
Related Party Transactions 29	58,530
Related Party Transactions 30	$ 240,000

INCOME TAXES (Narrative) (Detai

INCOME TAXES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Income Taxes 1	$ 15,831,371
Income Taxes 2	$ 14,371,847
Income Taxes 3	100.00%

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)yrdmoCAD / mo$ / moshares	CADyrdmoCAD / mo$ / moshares
Commitments And Contingencies 1 | CAD		CAD 8,925
Commitments And Contingencies 2 | d	90	90
Commitments And Contingencies 3 | mo	12	12
Commitments And Contingencies 4 | CAD / mo	12,000	12,000
Commitments And Contingencies 5	5.00%	5.00%
Commitments And Contingencies 6 | CAD / mo	600	600
Commitments And Contingencies 7 | yr	2	2
Commitments And Contingencies 8 | CAD		CAD 864,000
Commitments And Contingencies 9 | mo	18	18
Commitments And Contingencies 10	$ 230,892
Commitments And Contingencies 11 | CAD / mo	7,000	7,000
Commitments And Contingencies 12 | d	30	30
Commitments And Contingencies 13 | $ / mo	5,000	5,000
Commitments And Contingencies 14 | $ / mo	7,000	7,000
Commitments And Contingencies 15 | d	30	30
Commitments And Contingencies 16 | $ / mo	5,000	5,000
Commitments And Contingencies 17 | d	30	30
Commitments And Contingencies 18 | CAD		CAD 3,000
Commitments And Contingencies 19 | CAD / mo	1,500	1,500
Commitments And Contingencies 20 | shares	100,000	100,000
Commitments And Contingencies 21	$ 0.32
Commitments And Contingencies 22 | CAD		CAD 0.35
Commitments And Contingencies 24 | $ / mo	5,500	5,500
Commitments And Contingencies 25 | mo	5	5
Commitments And Contingencies 26	$ 5,000
Commitments And Contingencies 27	4.50%	4.50%
Commitments And Contingencies 28	5.00%	5.00%
Commitments And Contingencies 29	2.00%	2.00%
Commitments And Contingencies 30 | shares	50,000	50,000
Commitments And Contingencies 31 | shares	25,000	25,000
Commitments And Contingencies 32	5,000	5,000
Commitments And Contingencies 33 | shares	150,000	150,000
Commitments And Contingencies 34 | d	30	30
Commitments And Contingencies 35	$ 5,593
Commitments And Contingencies 36 | CAD		CAD 6,399
Commitments And Contingencies 37	1,418
Commitments And Contingencies 38	60,000
Commitments And Contingencies 39	$ 35,000
Commitments And Contingencies 40 | CAD		CAD 15,000

SEGMENT DISCLOSURES (Narrative)

SEGMENT DISCLOSURES (Narrative) (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Segment Disclosures 1	$ 3,828
Segment Disclosures 2	20,351
Segment Disclosures 3	120,246
Segment Disclosures 4	0
Segment Disclosures 5	126,377
Segment Disclosures 6	$ 128,146

CONVERTIBLE DEBENTURES AND DE44

CONVERTIBLE DEBENTURES AND DEFERRED FINANCING COSTS (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)mo$ / sharesshares	CADmoCAD / sharesshares
Convertible Debentures And Deferred Financing Costs 1	$ 1,398,592
Convertible Debentures And Deferred Financing Costs 2 | CAD		CAD 1,549,000
Convertible Debentures And Deferred Financing Costs 3	$ 1,398,592
Convertible Debentures And Deferred Financing Costs 4 | CAD		CAD 1,549,000
Convertible Debentures And Deferred Financing Costs 5	12.00%	12.00%
Convertible Debentures And Deferred Financing Costs 6 | CAD / shares		CAD 0.50
Convertible Debentures And Deferred Financing Costs 7 | CAD		CAD 0.65
Convertible Debentures And Deferred Financing Costs 8	20	20
Convertible Debentures And Deferred Financing Costs 9 | CAD		CAD 0.65
Convertible Debentures And Deferred Financing Costs 10 | CAD		CAD 0.65
Convertible Debentures And Deferred Financing Costs 11 | mo	12	12
Convertible Debentures And Deferred Financing Costs 12	15.00%	15.00%
Convertible Debentures And Deferred Financing Costs 13 | mo	12	12
Convertible Debentures And Deferred Financing Costs 14	5.00%	5.00%
Convertible Debentures And Deferred Financing Costs 15 | mo	12	12
Convertible Debentures And Deferred Financing Costs 16	2.00%	2.00%
Convertible Debentures And Deferred Financing Costs 17 | shares	151,900	151,900
Convertible Debentures And Deferred Financing Costs 18 | CAD / shares		CAD 0.50
Convertible Debentures And Deferred Financing Costs 19	$ 157,293
Convertible Debentures And Deferred Financing Costs 20 | CAD		CAD 174,209
Convertible Debentures And Deferred Financing Costs 21	33,583
Convertible Debentures And Deferred Financing Costs 22	73,540
Convertible Debentures And Deferred Financing Costs 23	73,540
Convertible Debentures And Deferred Financing Costs 24	53,338
Convertible Debentures And Deferred Financing Costs 25	$ 20,202
Convertible Debentures And Deferred Financing Costs 26 | shares	1,801,480	1,801,480
Convertible Debentures And Deferred Financing Costs 27	$ 500,000
Convertible Debentures And Deferred Financing Costs 28	40,444
Convertible Debentures And Deferred Financing Costs 29	$ 540,444
Convertible Debentures And Deferred Financing Costs 30 | shares	1,801,480	1,801,480
Convertible Debentures And Deferred Financing Costs 31 | $ / shares	$ 0.30
Convertible Debentures And Deferred Financing Costs 32	$ 700,000
Convertible Debentures And Deferred Financing Costs 33	$ 97,716
Convertible Debentures And Deferred Financing Costs 34	2,297,044	2,297,044
Convertible Debentures And Deferred Financing Costs 35	$ 30,000
Convertible Debentures And Deferred Financing Costs 36	3,877
Convertible Debentures And Deferred Financing Costs 37	$ 3,024

CONVERTIBLE BRIDGE LOANS (Narra

CONVERTIBLE BRIDGE LOANS (Narrative) (Details) - 12 months ended Nov. 30, 2014	USD ($)$ / sharesshares	CADCAD / sharesshares
Convertible Bridge Loans 1	$ 199,342
Convertible Bridge Loans 2 | CAD		CAD 200,000
Convertible Bridge Loans 3	$ 199,342
Convertible Bridge Loans 4 | CAD		CAD 200,000
Convertible Bridge Loans 5	6.00%	6.00%
Convertible Bridge Loans 6	$ 11,961
Convertible Bridge Loans 7	6.00%	6.00%
Convertible Bridge Loans 8 | shares	100,000	100,000
Convertible Bridge Loans 9 | CAD / shares		CAD 0.50
Convertible Bridge Loans 10	$ 199,342
Convertible Bridge Loans 11	7,504
Convertible Bridge Loans 12	11,961
Convertible Bridge Loans 13	$ 218,807
Convertible Bridge Loans 14 | shares	736,078	736,078
Convertible Bridge Loans 15	$ 183,514
Convertible Bridge Loans 16	97,456
Convertible Bridge Loans 17 | CAD		CAD 100,000
Convertible Bridge Loans 18	$ 97,456
Convertible Bridge Loans 19 | CAD		CAD 100,000
Convertible Bridge Loans 20	6.00%	6.00%
Convertible Bridge Loans 21	$ 5,847
Convertible Bridge Loans 22	6.00%	6.00%
Convertible Bridge Loans 23 | shares	50,000	50,000
Convertible Bridge Loans 24 | CAD / shares		CAD 0.50
Convertible Bridge Loans 25	$ 97,456
Convertible Bridge Loans 26	2,980
Convertible Bridge Loans 27	5,847
Convertible Bridge Loans 28	106,283
Convertible Bridge Loans 29	11,107
Convertible Bridge Loans 30	67,746
Convertible Bridge Loans 31 | CAD		CAD 197,355
Convertible Bridge Loans 32 | CAD		200,000
Convertible Bridge Loans 33	$ 197,355
Convertible Bridge Loans 34 | CAD		CAD 200,000
Convertible Bridge Loans 35	6.00%	6.00%
Convertible Bridge Loans 36	$ 11,841
Convertible Bridge Loans 37	6.00%	6.00%
Convertible Bridge Loans 38 | shares	100,000	100,000
Convertible Bridge Loans 39 | $ / shares	$ 0.50
Convertible Bridge Loans 40	$ 197,355
Convertible Bridge Loans 41	5,093
Convertible Bridge Loans 42	11,841
Convertible Bridge Loans 43	214,289
Convertible Bridge Loans 44	22,394
Convertible Bridge Loans 45	125,925
Convertible Bridge Loans 46	147,812
Convertible Bridge Loans 47 | CAD		CAD 150,000
Convertible Bridge Loans 48	$ 147,812
Convertible Bridge Loans 49 | CAD		CAD 150,000
Convertible Bridge Loans 50	6.00%	6.00%
Convertible Bridge Loans 51	$ 8,869
Convertible Bridge Loans 52	6.00%	6.00%
Convertible Bridge Loans 53 | shares	75,000	75,000
Convertible Bridge Loans 54 | CAD / shares		CAD 0.50
Convertible Bridge Loans 55	$ 147,812
Convertible Bridge Loans 56	3,037
Convertible Bridge Loans 57	8,869
Convertible Bridge Loans 58	$ 159,718
Convertible Bridge Loans 59 | shares	537,300	537,300
Convertible Bridge Loans 60	$ 122,942

INVENTORY (Narrative) (Details)

INVENTORY (Narrative) (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Inventory 1	$ 120,246

SUBSEQUENT EVENTS (Narrative) (

SUBSEQUENT EVENTS (Narrative) (Details)	12 Months Ended
	Nov. 30, 2014CAD$ / mo
Subsequent Events 1 | $ / mo	7,000
Subsequent Events 2	CAD 15,000

Schedule of Depreciation Rate,

Schedule of Depreciation Rate, Plant and Equipment (Details)	12 Months Ended
	Nov. 30, 2014yr
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 1	30.00%
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 2	30.00%
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 3	20.00%
Summary Of Significant Accounting Policies Schedule Of Depreciation Rate, Plant And Equipment 4	5

Schedule of Accounts Payable an

Schedule of Accounts Payable and Accrued Liabilities (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 1	$ 35,885
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 2	48,494
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 3	53,338
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 4	72,182
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 5	58,035
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 6	161,405
Accounts Payable And Accrued Liabilities Schedule Of Accounts Payable And Accrued Liabilities 7	$ 106,529

Schedule of Share-based Compens

Schedule of Share-based Compensation and Assumptions as of March 19, 2014 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of March 19, 2014 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of March 19, 2014 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of March 19, 2014 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of March 19, 2014 4	151.63%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of March 19, 2014 5	0.16
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of March 19, 2014 6	$ 47,897

Schedule of Share-based Compe51

Schedule of Share-based Compensation and Assumptions as of May 9, 2014 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of May 9, 2014 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of May 9, 2014 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of May 9, 2014 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of May 9, 2014 4	205.42%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of May 9, 2014 5	0.24
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of May 9, 2014 6	$ 140,573

Schedule of Share-based Compe52

Schedule of Share-based Compensation and Assumptions as of July 25, 2014 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of July 25, 2014 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of July 25, 2014 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of July 25, 2014 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of July 25, 2014 4	152.35%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of July 25, 2014 5	0.28
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of July 25, 2014 6	$ 33,952

Schedule of Share-based Compe53

Schedule of Share-based Compensation and Assumptions as of September 11, 2014 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 11, 2014 1	2.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 11, 2014 2	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 11, 2014 3	0.00%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 11, 2014 4	170.42%
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 11, 2014 5	0.30
Stock Based Compensation Schedule Of Share-based Compensation And Assumptions As Of September 11, 2014 6	$ 529,188

Schedule of Share-based Compe54

Schedule of Share-based Compensation, Stock Options, Activity (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 1	$ 1,510,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 2	1,660,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 3	3,025,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 4	0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 5	(125,000)
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 6	(150,000)
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 7	(50,000)
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 8	0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 9	(1,000,000)
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 10	0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 11	0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 12	0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 13	3,360,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 14	1,510,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 15	3,360,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options, Activity 16	$ 1,510,000

Schedule of Share-based Compe55

Schedule of Share-based Compensation, Stock Options (Details)	12 Months Ended
	Nov. 30, 2014USD ($)	Nov. 30, 2013USD ($)
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 1	0.20
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 2	$ 35,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 3	0.42
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 4	$ 200,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 5	0.45
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 6	$ 100,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 7	0.31
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 8	$ 400,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 9	0.32
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 10	$ 150,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 11	0.32
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 12	$ 600,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 13	0.36
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 14	$ 1,875,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 15	$ 3,360,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 16	0.35
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 17	0.34
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 18	0.25
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 19	0.25
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 20	0.45
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 1		0.25
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 2		$ 175,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 3		0.20
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 4		$ 35,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 5		0.42
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 6		$ 200,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 7		0.45
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 8		$ 1,100,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 9		$ 1,510,000
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 10		0.42
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 11		$ 0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 12		$ 0
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 13		0.50
Stock Based Compensation Schedule Of Share-based Compensation, Stock Options 14		$ 0

Share-based Compensation Arrang

Share-based Compensation Arrangement by Share-based Payment Award, Remaining Contractual Term, Outstanding and Exercisable (Details)	12 Months Ended
	Nov. 30, 2014
Stock Based Compensation Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 1	4
Stock Based Compensation Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 2	2.6
Stock Based Compensation Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 3	4
Stock Based Compensation Share-based Compensation Arrangement By Share-based Payment Award, Remaining Contractual Term, Outstanding And Exercisable 4	2.6

Schedule of Stockholders' Equit

Schedule of Stockholders' Equity Note, Warrants or Rights, Activity (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 1	$ 4,319,000
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 2	0.19
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 3	$ 100,000
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 4	0.47
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 5	$ 50,000
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 6	0.47
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 7	$ 100,000
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 8	0.47
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 9	$ 75,000
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 10	0.47
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 11	$ 898,645
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 12	0.38
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 13	$ 0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 14	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 15	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 16	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 17	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 18	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 19	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 20	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 21	$ 5,542,645
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 22	0.23
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 23	$ 151,900
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 24	0.45
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 25	$ 0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 26	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 27	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 28	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 29	$ (850,000)
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 30	0.25
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 31	$ (50,000)
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 32	0.25
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 33	$ 0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 34	0
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 35	$ 4,794,545
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 36	0.24
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 37	$ 4,794,545
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 38	0.24
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 39	$ 5,542,645
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Activity 40	0.23

Schedule of Stockholders' Equ58

Schedule of Stockholders' Equity Note, Warrants or Rights, Weighted Average Remaining Contractual Term, Outstanding and Exercisable (Details)	12 Months Ended
	Nov. 30, 2014
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 1	0.9
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 2	1.6
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 3	0.9
Stock Purchase Warrants Schedule Of Stockholders' Equity Note, Warrants Or Rights, Weighted Average Remaining Contractual Term, Outstanding And Exercisable 4	1.6

Schedule of Property, Plant and

Schedule of Property, Plant and Equipment (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Plant And Equipment Schedule Of Property, Plant And Equipment 1	$ 37,573
Plant And Equipment Schedule Of Property, Plant And Equipment 2	33,159
Plant And Equipment Schedule Of Property, Plant And Equipment 3	37,573
Plant And Equipment Schedule Of Property, Plant And Equipment 4	31,267
Plant And Equipment Schedule Of Property, Plant And Equipment 5	18,027
Plant And Equipment Schedule Of Property, Plant And Equipment 6	15,212
Plant And Equipment Schedule Of Property, Plant And Equipment 7	18,027
Plant And Equipment Schedule Of Property, Plant And Equipment 8	14,006
Plant And Equipment Schedule Of Property, Plant And Equipment 9	23,721
Plant And Equipment Schedule Of Property, Plant And Equipment 10	13,151
Plant And Equipment Schedule Of Property, Plant And Equipment 11	23,721
Plant And Equipment Schedule Of Property, Plant And Equipment 12	10,057
Plant And Equipment Schedule Of Property, Plant And Equipment 13	209,515
Plant And Equipment Schedule Of Property, Plant And Equipment 14	83,138
Plant And Equipment Schedule Of Property, Plant And Equipment 15	171,890
Plant And Equipment Schedule Of Property, Plant And Equipment 16	4,374
Plant And Equipment Schedule Of Property, Plant And Equipment 17	288,836
Plant And Equipment Schedule Of Property, Plant And Equipment 18	144,660
Plant And Equipment Schedule Of Property, Plant And Equipment 19	251,211
Plant And Equipment Schedule Of Property, Plant And Equipment 20	99,074
Plant And Equipment Schedule Of Property, Plant And Equipment 21	144,176
Plant And Equipment Schedule Of Property, Plant And Equipment 22	152,137
Plant And Equipment Schedule Of Property, Plant And Equipment 23	45,586
Plant And Equipment Schedule Of Property, Plant And Equipment 24	$ 38,130

Summary of Tax Credit Carryforw

Summary of Tax Credit Carryforwards (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Income Taxes Summary Of Tax Credit Carryforwards 1	$ 188,494
Income Taxes Summary Of Tax Credit Carryforwards 2	609,991
Income Taxes Summary Of Tax Credit Carryforwards 3	1,731,495
Income Taxes Summary Of Tax Credit Carryforwards 4	3,174,989
Income Taxes Summary Of Tax Credit Carryforwards 5	2,792,560
Income Taxes Summary Of Tax Credit Carryforwards 6	2,044,857
Income Taxes Summary Of Tax Credit Carryforwards 7	854,218
Income Taxes Summary Of Tax Credit Carryforwards 8	1,073,610
Income Taxes Summary Of Tax Credit Carryforwards 9	1,410,557
Income Taxes Summary Of Tax Credit Carryforwards 10	1,950,600
Income Taxes Summary Of Tax Credit Carryforwards 11	$ 15,831,371

Schedule of Reconcilation of In

Schedule of Reconcilation of Income Tax Expense (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 1	$ (2,722,412)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 2	$ (2,024,211)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 3	35.00%
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 4	35.00%
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 5	$ (952,844)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 6	(708,474)
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 7	270,134
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 8	60,566
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 9	682,710
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 10	647,908
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 11	0
Income Taxes Schedule Of Reconcilation Of Income Tax Expense 12	$ 0

Schedule of Effective Income Ta

Schedule of Effective Income Tax Rate Reconciliation (Details)	12 Months Ended
	Nov. 30, 2014
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 1	35.00%
Income Taxes Schedule Of Effective Income Tax Rate Reconciliation 2	(35.00%)

Schedule of Deferred Tax Assets

Schedule of Deferred Tax Assets and Liabilities (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 1	$ 15,831,371
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 2	$ 14,371,847
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 3	35.00%
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 4	35.00%
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 5	$ (5,540,980)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 6	(5,030,146)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 7	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 8	(239,958)
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 9	5,540,980
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 10	5,270,104
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 11	0
Income Taxes Schedule Of Deferred Tax Assets And Liabilities 12	$ 0

Schedule of Convertible Debt (D

Schedule of Convertible Debt (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 1	$ 1,398,342
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 2	(1,279,773)
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 3	(190,876)
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 4	33,583
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 5	16,681
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 6	21,793
Convertible Debentures And Deferred Financing Costs Schedule Of Convertible Debt 7	$ 1,398,592

Schedule of Convertible Bridge

Schedule of Convertible Bridge Loans, Face Value $199,342 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $199,342 1	$ 199,342
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $199,342 2	(199,342)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $199,342 3	159,268
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $199,342 4	24,246
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $199,342 5	$ 15,828

Schedule of Convertible Bridg66

Schedule of Convertible Bridge Loans, Face Value $97,456 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $97,456 1	$ 97,456
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $97,456 2	(97,456)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $97,456 3	56,477
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $97,456 4	11,269
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $97,456 5	$ 29,710

Schedule of Convertible Bridg67

Schedule of Convertible Bridge Loans, Face Value $197,355 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $197,355 1	$ 197,355
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $197,355 2	(197,355)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $197,355 3	105,423
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $197,355 4	20,502
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $197,355 5	$ 71,430

Schedule of Convertible Bridg68

Schedule of Convertible Bridge Loans, Face Value $147,812 (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $147,812 1	$ 147,812
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $147,812 2	(147,812)
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $147,812 3	101,422
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $147,812 4	21,520
Convertible Bridge Loans Schedule Of Convertible Bridge Loans, Face Value $147,812 5	$ 24,870

Schedule of Income from Derivat

Schedule of Income from Derivatives (Details)	12 Months Ended
	Nov. 30, 2014USD ($)
Derivative Financial Instruments Schedule Of Income From Derivatives 1	$ 199,342
Derivative Financial Instruments Schedule Of Income From Derivatives 2	136,402
Derivative Financial Instruments Schedule Of Income From Derivatives 3	97,456
Derivative Financial Instruments Schedule Of Income From Derivatives 4	45,370
Derivative Financial Instruments Schedule Of Income From Derivatives 5	197,355
Derivative Financial Instruments Schedule Of Income From Derivatives 6	83,029
Derivative Financial Instruments Schedule Of Income From Derivatives 7	147,812
Derivative Financial Instruments Schedule Of Income From Derivatives 8	84,731
Derivative Financial Instruments Schedule Of Income From Derivatives 9	$ 349,532